Oneness Biotech Co., Ltd. (TPEX: 4743)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
106.00
-0.50 (-0.47%)
Nov 21, 2024, 11:59 AM CST
-46.10%
Market Cap 50.85B
Revenue (ttm) 112.20M
Net Income (ttm) -1.26B
Shares Out 477.46M
EPS (ttm) -2.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,208,669
Open 107.00
Previous Close 106.50
Day's Range 105.50 - 108.00
52-Week Range 101.00 - 200.96
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Oneness Biotech

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 4743
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.